Journal of Stem Cells

Editor-in-Chief: Dr. Prasad S. Koka (prasad.koka@novapublishers.com)
ISSN: 1556-8539
Frequency: Quarterly
Binding: Softcover
Size: 8.5 x 11, Double column

Journal of Stem Cells publishes papers on all aspects of stem cell research, including, but not limited to, the following topics.
Reproduction of Stem Cells: Self-renewal (role of transcription factors), multilineage differentiation, signaling pathways in differentiation, totipotency and pluripotency
Embryonic Stem Cells: Organ generation (Organogenesis), sites of proliferation and differentiation, trans-dermal differentiation, and organ specific trans-localization and development
Hematopoietic Stem Cells: Early (primitive) and late progenitors, differentiation (role of c-Mpl, thrombopoietin, homeobox, cytokines, growth factors, inhibitors)
Neural Stem Cells: Sites of generation and localization
Mesenchymal Stem Cells: Beneficial roles of these cellular factors in clinical applications including bodily injury and transplantation
Cardiovascular Stem Cells: Cardiomyocytes, Endothelial cells
Stem Cells in Disease: Stem cells in congenital cytopenias, Stem cells in infection (HIV, hepatitis, other), Stem cells in cancer and leukemia (abnormal proliferation), Stem cells in autoimmune diseases, including Multiple Sclerosis and Diabetes, Stem cells in Parkinson’s, Stem cells in retina and Glaucoma (optic-nerve cell degeneration), Stem cells in aging including Alzheimer’s, Stem cells in regeneration and degeneration
Chimeric Animal Models for Human Stem Cells: Stem cell transplantation and reconstitution in vivo
Autologous Stem Cell Transplantation and Reconstitution: Different species and including primates and humans for studies on development, localization, and therapeutic strategies
Gene Delivery through Stem Cells: Vectors, lineage specificity of endogenous and exogenous stem cell gene expression
Stem Cells in Therapy: Therapeutic regeneration of molecularly engineered and transplanted autologous stem cells in neurological and cardiovascular diseases due to inability of self-regeneration / repair of endogenous stem cells at sites of inflammation or disease
Cancer Stem Cells: In vivo generation, role in malignancies such as disease development, progression including to next phase, relapse, metastasis, susceptibility in cancer treatment, presence in terminal phase of illness
Regenerative Medicine
Translational Research
Current and New Perspectives in Stem Cell Research
Stem Cells and Complementary and Alternative Medicines
______________________________________________________________________________
Please follow this link and be taken directly to a featured open access article from the Journal of Stem Cells, issue 9#3.

“Biomarker Discovery and Biotherapeutics Applications of Photosynthetic Light-Harvesting and Bioluminescence Light-Emitting Chromophore-Protein Complexes in Stem Cell Biology and Regenerative Medicine”
______________________________________________________________________________
Journal of Stem Cells is abstracted in indexes owned by Elsevier (Scopus), ProQuest, EBSCO, and Chemical Abstracts Society (CAS).

Categories: ,

EDITOR-IN-CHIEF
Dr. Prasad S. Koka
National Professor & Visiting Scientist of Virology and Immunology
Haffkine Institute for Training Research and Testing, Mumbai, India
E-mail: prasad.koka@novapublishers.com

Featured Scientific Article by Dr. Prasad S. Koka
“Biomarker Discovery and Biotherapeutics Applications of Photosynthetic Light-Harvesting and Bioluminescence Light-Emitting Chromophore-Protein Complexes in Stem Cell Biology and Regenerative Medicine”

This article is available via Open Access: http://www.novapublishers.org/catalog/product_info.php?products_id=50899

(*SEE EDITOR’S CV BELOW*)

ASSOCIATE EDITOR

Dr. Inger Birgitta Sundell-Ranby
Department of Anthropology
Wayne State University
Detroit, Michigan, USA
E-mail: du2557@wayne.edu

EDITORIAL ADVISORY BOARD

Dr. Richard K. Burt
Division of Immunotherapy, Department of Medicine
Northwestern University Feinberg School of Medicine
Chicago, Illinois, USA
E-mail: rburt@northwestern.edu

Dr. Connie J. Eaves
Terry Fox Laboratory
University of British Columbia
Vancouver, British Columbia, Canada
E-mail: ceaves@bccancer.bc.ca

Dr. Ahmed El-Hashash
Biomedicine, Stem Cell & Regenerative Medicine
University of Edinburgh-ZJU Institute
Haining, Zhejiang, China
E-mail: hashash05@yahoo.co.uk

Dr. Stan Gronthos
Hanson Institute
University of Adelaide
Adelaide, Australia
E-mail: stan.gronthos@imvs.sa.gov.au

Dr. Wasim Khan
University of Cambridge and Addenbrooke's Hospital
Trauma and Orthopaedic Surgery
E-mail: wasimkhan@doctors.org.uk

Dr. Tomohiko Kisaka
Translational Research Center, Hiroshima University
School of Biodesign, All India Institute of Medical Sciences
AIIMS | Hiroshima Uni | IIT Delhi | BCIL | Tottori Uni
E-mail: tomohiko.2017@biodesign.school

Dr. Toshio Kitamura
The Institute of Medical Science
University of Tokyo
Tokyo, Japan
E-mail: kitamura@ims.u-tokyo.ac.jp

Dr. J. Michael McCune
Chief, Division of Experimental Medicine
University of California at San Francisco
San Francisco, California, USA
E-mail: Mike.McCune@ucsf.edu

Dr. Michel Puceat
INSERM UMR 910
Faculté de Médecine La Timone
13885 Marseille, France
E-mail: michel.puceat@inserm.fr

Dr. Christina M. Ramirez
Professor of Biostatistics
UCLA Fielding School of Public Health
Los Angeles, California, USA
E-mail: cr@ucla.edu

Dr. David Scadden
Harvard Department of Stem Cell and Regenerative Biology
Massachusetts General Hospital
Boston, Massachusetts, USA
E-mail: dscadden@mgh.harvard.edu

Dr. Alka Sharma
Department of Biotechnology
Ministry of Science and Technology
New Delhi, Delhi, India
E-mail: alka.dbt@nic.in

Dr. Sarah E. Webb (Ho)
Division of Life Science
HKUST, Clear Water Bay
Kowloon, Hong Kong
E-mail: barnie@ust.hk

REVIEWERS
Bhishma Amlani, Developmental Biology, New York University, New York, USA
Palas Kumar Chanda, Houston Methodist Research Institute, Houston, USA
Songjie Chen, Metabolomics & Proteomics, Stanford University, Stanford, USA
Jun Cui, Cornell University, Ithaca, USA
Suhasni Gopalakrishnan, University of Southern California, Los Angeles, USA
Yuning Hou, Center for Molecular and Translational Medicine, Georgia State University, Atlanta, USA
Rajneesh Jha, Cardiomyocyte Stem Cell Laboratory, Emory Univ. School of Medicine, Atlanta, USA
Riya Kanherkar, Howard University, Washington DC, USA
Suhail Khoja, Department of Medicine, University of California, Los Angeles, USA
Gauri Kulkarni, Wake Forest Inst. for Regenerative Medicine, Winston-Salem, North Carolina, USA
Akhilesh Kumar, Wisconsin National Primate Research Center, Madison, USA
Nan Li, University of Texas Health Science Center, Houston, USA
Liu Liu, Cardiac Surgery Department, University of Michigan, Ann Arbor, USA
Yifei Liu, Yale Stem Cell Center, New Haven, USA
Jie Luo, University of Washington, Seattle, USA
Siu Ping Ngok, Stanford University School of Medicine, Stanford, USA
Bhagat Patlolla, International Technological University, San Jose, USA
Indulekha Pillai, Cedars Sinai Medical Center, Los Angeles, USA
Alfredo Procino, University of Naples "Federico II,” Italy
Xuefeng Qiu, Department of Bioengineering, University of California, Los Angeles, USA
Pavan Rajanahalli, University of Florida, Gainesville, USA
Kanchan Sarda, Department of Orthopaedic Surgery, University of California, San Francisco, USA
Jian Shu, Broad Institute of MIT and Harvard, Whitehead Inst. for Biomedical Research, Massachusetts, USA
Praveen Kumar Chandranath Shukla, Stanford University School of Medicine, Stanford, USA
Pulavendran Sivasami, Oklahoma State University, Stillwater, USA
Yunlong Tao, Waisman Center, University of Wisconsin, Madison, Wisconsin, USA
Lei Teng, Center for Cardiovascular Sciences, Albany Medical College, Albany, USA
Mahdi Tondar, University of California, Los Angeles, USA
Zhixiang Tong, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA
Chenran Wang, Department of Cancer Biology, University of Cincinnati, Cincinnati, USA
Yefei Wen, The University of Texas, Houston, USA
Shaogen Wu, Rutgers the State University of New Jersey, Newark, USA
Guorui Xie, Gladstone Institute of Virology and Immunology, University of California, San Francisco, USA
Yonggang Xie, Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, USA
Pengfei Xu, Department of Developmental Biology, University of Southern California, Los Angeles, USA
Mei Yang, University of Southern California, Los Angeles, California, USA
Xue Yu, The Scripps Research Institute, La Jolla, USA
Jinyun Yuan, Saint Louis University School of Medicine, St. Louis, USA
Bing Zhang, Dept. of Stem Cell and Regenerative Biology, Harvard University, Massachusetts, USA
Danhua Zhang, University of California, San Diego, USA
Yu Zhang, The J David Gladstone Institutes, University of California, San Francisco, USA
Qingshi (Erik) Zhao, New Jersey Medical School and Rutgers University, Rutgers, USA
Wei Zhao, The Methodist Hospital Research Institute, Houston, USA
Ting Zhou, Weill Cornell Medical College, New York, USA
Fangfang Zhu, Lorry I. Lokey Stem Cell Research Building, Stanford, USA
Jun Zou, Cardiovascular Research Institute, University of California, San Francisco, USA
________________________________________________________________________________________________________________________________________________________

EDITOR’S CURRICULUM VITAE

DR. PRASAD S KOKA, PHD

Editor-in-Chief, Journal of Stem Cells, www.novapublishers.org/JSC
Nova Science Publishers, Hauppauge, New York, United States

Editor-in-Chief, Stem Cell Biology and Research, www.hoajonline.com/stemcells
Herbert Publications, Bedfordshire, United Kingdom

Honorable Editor, Journal of Human Virology and Retrovirology, http://medcraveonline.com/JHVRV
MedCrave Group Journals, Edmond, Oklahoma, United States

Honorable Editor, Hematology & Transfusion International Journal, http://medcraveonline.com/HTIJ
MedCrave Group Journals, Edmond, Oklahoma, United States

Computers in Biology and Medicine (CBM), https://ees.elsevier.com/cbm/
Elsevier Editorial Systems (EES)

Editor, Haematology International Journal (HIJ), http://medwinpublishers.com/HIJ/editorial-board.php
Medwin Publishers, Troy, Michigan, United States

Editorial Board, Molecular Biology and Genetic Engineering, http://www.hoajonline.com/molbiolgeneteng
Herbert Publications, Bedfordshire, United Kingdom

Editorial Board, Current Research in Stem Cell and Regenerative Medicine, crscrm@kenkyugroup.co.uk
Kenkyu Publishing Group, Hyderabad, India

Editorial Board, Journal of Stem Cell Research & Regenerative Medicine, www.enlivenarchive.org/stem-cell-research-regenerative-medicine
Enliven Archive, Dover, Delaware, United States

Editorial Board, Indian Journal of Case Reports, Atharva Scientific Publications, Bhopal, India

Editorial Board, ARC Journal of Surgery (AJS), ARC Publications Pvt. Ltd., Ongole, India

________________________________________________________________________________________________________________________________________________________

TRANSLATIONAL R & D ● BIOMEDICAL SCIENCES ● STEM CELLS ● REGENERATIVE MEDICINE

Applications of mesenchymal stem cells in regenerative medicine: (1) their potential role in the increased half-life of cardiomyocytes, (2) latest technologies of FCXM and HLA matching in organ transplantation, and (3) in the formation or curtailment of cancer stem cells from embryonic stem cells differentiation

Pre-clinical Translational Humanized In Vivo Mouse Model Systems - NOD/SCID-hu Mice (Human Fetal Thymus/Liver Conjoint Organ Growth +/- Autologous CD34 Cell Engrafted), Generation of Cancer Stem Cells using these Chimeric Humanized Mice In Vivo/Ex Vivo and In Vitro, Gene and Drug Therapy for Rescue from Hematopoietic Cell Dysfunction in HIV Infection, Safer and Greater Efficacy Drug for HIV Replication and Rescue of Hematopoiesis, Molecular Factors, Mechanisms and Therapies of Hematological Disorders in HIV Infection and in Mother-to-Child Transmission of HIV Infection, Host Cellular Factors in HIV Induced Hematological Disorders, Role of microRNA and its characterization in this context

________________________________________________________________________________________________________________________________________________________

PROFESSIONAL EXPERIENCE

HAFFKINE INSTITUTE FOR TRAINING RESEARCH AND TESTING, MUMBAI, INDIA, 2013 – 2019
Professor (2013-Present) and National Professor & Visiting Scientist of Virology and Immunology (2014-2019)
Hematological disorders in HIV infection; Generation and characterization of cancer stem cells in vitro

GLOBAL GENE CORPORATION, MUMBAI, INDIA, 2016
Head – Cancer Stem Cells
Initiating new projects and seeking governmental regulatory approvals

SRI SHRIDEVI RESEARCH FOUNDATION and SRI SHRIDEVI CHARITABLE TRUST, TUMAKURU, INDIA, 2013 – 2015
Scientific Director
In charge of all the institutions and centres that are part of these establishments to consolidate research efforts

SHRIDEVI INSTITUTE OF MEDICAL SCIENCES & RESEARCH HOSPITAL, TUMAKURU, INDIA, 2013 – 2015
Additional Professor of Biochemistry
Research and teaching duties for medical students

MERISIS THERAPEUTICS - DIPONED BIOINTELLIGENCE LLP, BANGALORE, INDIA, 2012–2016
Scientific Director; Chief Scientific Director; Professor of DiponEd Institute of Regenerative Medicine
R&D, servicing no-option medical conditions through development of products comprising stem cells and minimally invasive treatments; Stem Cell Biology and Regenerative Medicine based therapies

GENELUX CORPORATION, SAN DIEGO, CALIFORNIA, USA, 2011–2012
Chief Advisor for Stem Cell Biology and Oncolytic Viral Therapy
Targeted delivery of candidate anti-tumor drugs via vaccinia virus recombinants using humanized mouse model systems

MINISTRY OF SCIENCE & TECHNOLOGY, DEPARTMENT OF BIOTECHNOLOGY, NEW DELHI, INDIA, 2010 – Present
Professor of Virology and Immunology, SVYASA University, Bengaluru (2010-2012); Haffkine Institute, Mumbai (2012-Present)
Isolation of placental cells for role of host factors in HIV mediated indirect effects such as in mother to child transmission of HIV infection – potential role of putative cellular factors – Characterization of cellular host or viral factors in HIV induced hematopoietic inhibition - Government of India funded (2010-2015)

AVESTHAGEN PVT LTD, BANGALORE, INDIA, 2007 – 2009
Chief Scientific Officer and Head – Cancer Stem Cells
Directed differentiation of pluripotent stem cells into hepatocytes and their amplification

TORREY PINES INSTITUTE FOR MOLECULAR STUDIES, SAN DIEGO, CALIFORNIA, USA, 2004-2010
Associate Member (“Associate Professor”) and Head of Laboratory of Stem Cell Biology, Division of Immunology, Molecular Genetics and Cell Biology
Role of c-Mpl in HIV-1 induced cytopenias – US NIH/NHLBI R0-1 funded – gene therapy, lentivirus transduction, humanized mice, rescue of hematopoiesis; generation and characterization of cancer stem cells in vivo in humanized severe combined immunodeficient (SCID-hu) mice

DAVID GEFFEN SCHOOL OF MEDICINE, UNIVERSITY OF CALIFORNIA, LOS ANGELES, CALIFORNIA, USA, 1989 – 2004
Research Faculty Positions

Associate Researcher, Department of Molecular & Medical Pharmacology, 2002 – 2004
Mechanisms of HIV-1 induced hematopoietic inhibition – California HIV/AIDS Research Program funded – gene targeting in humanized mice

Assistant Research Virologist, Department of Microbiology, Immunology and Molecular Genetics, 2000 – 2002
In vitro tissue culture design for hepatitis C virus and co-culture with HIV-1 – UCLA AIDS Institute funded – work patented

Assistant Research Biologist, Division of Hematology-Oncology, Department of Medicine, 1995 – 2000
Establishment of inhibition of hematopoiesis in HIV-1 infection in vivo in humanized mice and in vitro in cell culture; humanized mice are generated by the transplantation of the thymus/liver tissues under the kidney capsule of the severe combined immunodeficient mice, SCID-hu – Elizabeth Glaser Pediatric AIDS Foundation Scholar Award funded

Assistant Research Neurologist, Department of Neurology, 1992 – 1995
Cytokine secretion by human brain tissue derived microglia and astrocytes following infection with HIV-1 envelope protein gp120/160/41-vaccinia virus recombinants as mechanisms for AIDS dementia – National Institute of Mental Health – NIH funded

Assistant Research Immunologist, Histocompatibility / Immunogenetics Center, Department of Surgery / Pathology, 1989 – 1992
Donor-recipient histocompatibility antigens matching for human organ transplantation – University of California Medical Center Clinical Services funded

DANA FARBER CANCER INSTITUTE, HARVARD MEDICAL SCHOOL, BOSTON, MASSACHUSETTS, USA, 1985 – 1989
Instructor in Pathology, Harvard Medical School, Division of Pediatric Oncology, 1988 – 1989
Research Fellow in Pathology, Harvard Medical School, Divisions of Immunogenetics and Pediatric Oncology, 1985 – 1988

Transcriptional regulation of human CD4 expression by HIV-1 Tat protein; transcriptional regulation of the human T-cell immune response antigens by murine retroviral sequences – Leukemia Society of America Special Fellowship funded

MASSACHUSETTS INSTITUTE OF TECHNOLOGY (MIT), CAMBRIDGE, MASSACHUSETTS, USA, 1983 – 1985
Postdoctoral Associate, Center for Cancer Research, Department of Biology
Tissue tropism of the Moloney and Friend murine retroviral transcriptional enhancer sequences in causing thymic and erythro leukemias respectively

COLD SPRING HARBOR LABORATORY, COLD SPRING HARBOR, NEW YORK, USA, 1981 – 1983
Postdoctoral Fellow, Bacteriophage Mu (µ) Laboratory
Molecular characterization of the Mu transposition proteins at the genomic and protein levels

BROOKHAVEN NATIONAL LABORATORY, UPTON, NEW YORK, USA, 1979 – 1981
Research Associate, Department of Biology
Involvement of ATP as a cofactor in the DNA repair mechanism of the photoreactivating enzyme of Escherichia coli

UNIVERSITY OF GEORGIA, ATHENS, GEORGIA, USA, 1977 – 1979
Postdoctoral Fellow, Department of Biochemistry and Molecular Biology
Identification and characterization of the light emitter in the bioluminescent bacterium Photobacterium phosphoreumas the riboflavin precursor, 6,7-dimethyl-8-ribityl lumazine, from which riboflavin (vitamin B2) is known to be generated by action of riboflavin synthase

TEXAS TECH UNIVERSITY, LUBBOCK, TEXAS, USA, 1973 – 1977
Doctoral Degree Graduate Student and Part-time Instructor (Biochemistry; General Chemistry; Organic Chemistry)
PhD degree dissertation produced the characterization of energy transfer and molecular topology of a unique biological fluorescence label, peridinin-chlorophyll a-protein (PerCP) from marine dinoflagellates, which has subsequently been used in applications for detection of antigens that is now widely used in flow cytometry (FACS) with PerCP labeled antibody binding to target molecules on the mammalian cell surface – Robert A. Welsh Foundation Pre-doctoral Fellowship funded

UNIVERSITY OF MISSOURI, COLUMBIA, MISSOURI, USA, 1970 – 1973
Master’s Degree Graduate Student and Teaching Assistant (General Chemistry; Organic Chemistry)
Master’s degree thesis on the photosensitizer properties of flavin mononucleotide and its photoreduction

UNIVERSITY OF MIAMI, CORAL GABLES, FLORIDA, USA, 1969 – 1970
Master’s Degree Graduate Student and Teaching Assistant (General Chemistry; Organic Chemistry)
Gaseous phase ultraviolet light photochemistry
________________________________________________________________________________________________________________________________________________________

ACADEMIA

1977 PhD (Major – Biochemistry: Minor - Physical Chemistry: Degree - Doctorate), Texas Tech University, Lubbock, Texas, USA, 1973-1977
Doctoral dissertation dealt with energy transfer from the carotenoid, peridinin, to chlorophyll a, in a unique biological fluorescence label, peridinin-chlorophyll a-protein (PerCP), for antibodies that is now widely used in flow cytometry for detection of antibody binding to target molecules on the cell surface.

1973 AM (Major - Physical Chemistry: Degree - Master of Arts - Chemistry), University of Missouri, Columbia, Missouri, USA, 1970-1973
Master’s degree thesis dealt with photoreduction of flavin mononucleotide (FMN)

1969-70 Master’s Degree Graduate Student (Major - Physical Chemistry), University of Miami, Coral Gables, Florida, USA

1967-69 Master’s Degree Graduate Student (Major - Analytical Chemistry), Osmania University, Hyderabad, India

1967 BSc (Majors - Chemistry, Physics, Mathematics), Degree - Bachelor of Science, Osmania University, Hyderabad, India, 1964-1967
________________________________________________________________________________________________________________________________________________________

AWARDS / GRANTS

  • Ministry of Science & Technology, Department of Biotechnology (DBT), India, 2010 – 2015
  • American Society of Hematology Award of Excellence, 2007
  • National Institutes of Health (NIH), National Heart Lung and Blood Institute (NHLBI), USA, 2004 – 2010
  • California HIV/AIDS Research Program (CHRP), USA, 2002 – 2004
  • University of California Los Angeles (UCLA) AIDS Institute, USA, 2000 – 2001
  • Elizabeth Glaser Pediatric AIDS Foundation Scholar, USA, 1996 – 1998
  • National Institutes of Health (NIH), National Institute of Mental Health (NIMH), USA, 1992 – 1995
  • Leukemia Society of America Special Fellow, USA, 1985 – 1987
  • Robert A. Welch Foundation Pre-doctoral Fellow, USA, 1975 – 1977

________________________________________________________________________________________________________________________________________________________

HONORS / COMMITTEES / JOURNALS

  • Presided the session on Bioluminescence & Chronobiology, 9th Annual Meeting, American Society for Photobiology, Asilomar, California, 1979
  • Selected speaker at the Biannual International Congress on Photobiology, Strasbourg, France, 1980
  • Invited speaker at Centre for Cellular and Molecular Biology, Hyderabad, India, 1982
  • Invited speaker at National Institute of Immunology, New Delhi, India, 1982
  • Invited speaker at Indian Institute of Science, Bangalore, India, 1982
  • Selected speaker at the 5th HLA and Histocompatibility Workshop, Les Avants, Switzerland, 1986
  • Invited speaker, University of Wisconsin, Madison, USA, 1989
  • Invited speaker (invited by Dr. Flossie Wong-Staal), National Institutes of Health, Bethesda, Maryland, USA, 1989
  • Invited speaker, Hoffman LaRoche, Nutley, New Jersey, USA, 1989
  • Invited speaker, University of Tulane Medical Center, New Orleans, Louisiana, USA, 1989
  • Invited speaker at Centre for Cellular and Molecular Biology, Hyderabad, India, 1992
  • Selected speaker at the Biannual International Congress on Transplantation and Immunogenetics, Paris, France, 1992
  • Invited speaker, Louisiana State University Medical Center, New Orleans, USA, 1993
  • Invited speaker at M D Anderson Cancer Center, Houston, Texas, 1993
  • Plenary Session Speaker at the Annual University of California Los Angeles (UCLA) AIDS Symposium, 1993
  • Invited speaker at International Centre for Genetic Engineering and Biotechnology, New Delhi, India, 2003
  • Invited speaker at Centre for Cellular and Molecular Biology, Hyderabad, India, 2003
  • Honorary Member, International Advisory Council, SVYASA University, Bangalore, India, since 2003
  • Invited speaker (invited by Dr. Kenneth Kaushansky - Chair of Medicine), University of California, San Diego, USA, 2005
  • Reviewer, Scottish Executive Health Department, Edinburgh, United Kingdom, 2005 – 2006
  • Reviewer, AIDS Vaccines and Immunology Special Emphasis Panel, Center for Scientific Review, National Institutes of Health, USA, 2006
  • Inclusion in the 9th Edition of Marquis Who’s Who in Science and Engineering, 2006 – 2007
  • Reviewed for the Journal of Clinical Investigation, 2006
  • Member, Peer Review Committee, American Heart Association, Western Review Consortium, 2006 – 2010
  • Submitted industrial-academic grant proposals between Avesthagen and University College London (UCL) to SC4SM. SC4SM = Stem Cells for Safer Medicines (UK), 2007
  • Member, Organizing Committee, The Stem Cell Partnering Series, Vancouver, British Columbia, Canada, 2007
  • American Society of Hematology: Award of Excellence May 1, 2007 for significant contribution to the field of Hematology
  • Inclusion in the 62ndEdition of Marquis Who’s Who in America, 2008
  • Inclusion in the 25thEdition of Marquis Who’s Who in the World, 2008
  • Reviewed for the journal Tuberculosis and The Journal of Infectious Diseases, 2008
  • Invited to the California HIV/AIDS Research Program (CHRP) stakeholder input meetings as part of their ongoing strategic planning process, San Francisco, CA, 2008
  • Member, Advisory Board, The Stem Cell Partnering Series, Vancouver, British Columbia, Canada, 2009
  • Session Moderator for the Fostering Business Collaborations Sessions, Stem Cell Partnering Series 2nd Annual Meeting, La Jolla, CA, 2009
  • Reviewed for the journals Acta Hematologica and Current HIV Research, 2010
  • Invited to review grants for the Italian Ministry of Health, 2010
  • Editorial Board Member, World Journal of Virology, Beijing, China, 2011 – 2015
  • External reviewer of doctoral dissertation in the field of hematological malignancies for University of Calcutta, India
  • Invitation to meet the Karger Publishers CEO, Ms. Gabriella Karger- S. Karger AG, Medical and Scientific Publishers, Basel, Switzerland, 2012
  • Reviewer for International Journal of Yoga (IJOY), 2011 – 2012
  • Listed in 2012 by BioMedLib (www.BioMedLib.com) as 1 in top 20 Articles published on the same topic. Placental membrane as a source of mesenchymal stem cells. Sundell IB, Koka P. J Stem Cells; 2010; 5(2):83-88.
  • Standing reviewer for the journal Current HIV Research published by Bentham Science Publishers (USA), 2012 – Present
  • Chairman, Institutional Committee for Stem Cell Research and Therapy (IC-SCRT at Merisis Therapeutics (DiponEd BioIntelligence LLP, Bangalore), with approval from Indian Council for Medical Research National Apex Committee for Stem Cell Research and Therapy (ICMR NAC-SCRT), 2012 – Present
  • Editorial Board Member, Journal of Sexually Transmitted Diseases, Hindawi Publishing Corporation, New York, 2012 – Present
  • Reviewer for the journal Human Gene Therapy published by Mary Ann Liebert Publishers (USA), 2013 – Present
  • My/our 2010 paper in Virology (doi:10.1016/j.virol.2010.03.005) has been featured in 2013 on the use of CD34 antibodies (clones QBEND/10 and AC136). Webpage of The #1 Antibody Resource: http://www.antibodyresource.com/rateproduct/doi/10.1016/j.virol.2010.03.005/pkoka_at_tpims.org
  • Reviewed for the World Journal of Gastroenterology, 2013
  • Invited Continuing Medical Education (CME) lecture at Fortis Hospital, Bangalore, March 2013
  • Invitations from the journals Hematology and Leukemia (Herbert Publications, UK); Virology: Research and Treatment (Libertas Academica la-press.com); Virology Discovery (Herbert Publications, UK); Immunological Reviews; and Current HIV Research (Bentham Science Publishers, USA) to submit manuscripts for publication
  • The #1 Antibody Resource: Featured in 2013 my/our 2010 paper in Virology (doi:10.1016/j.virol.2010.03.005 ) on the use of CD38 antibodies (clone IB6). Webpage: http://www.antibodyresource.com/rateproduct/doi/10.1016/j.virol.2010.03.005/pkoka_at_tpims.org
  • Reviewed for the World Journal of Virology, 2013
  • Re-listed in 2013 by BioMedLib (www.BioMedLib.com) as our paper continues to be 1 in top 20 Articles published on the same topic. “Placental membrane as a source of mesenchymal stem cells.” Sundell IB, Koka P. J Stem Cells; 2010; 5(2):83-88.
  • Editorial Board Member, Current HIV Research, www.benthamscience.com/journals/current-hiv-research/ Bentham Science Publishers, USA, chivr@benthamscience.org 2013 – Present
  • Reviewer for the journal, Stem Cells International, Hindawi Publishing Corporation, New York, 2013 – Present
  • Consultant on induced pluripotent stem cells (iPSC) for Guidepoint Global, New York, USA
  • Invited to review grants for the Italian Ministry of Health, 2013
  • Editorial Board Member, for the journal, Stem Cell Biology and Research, Herbert Publications, United Kingdom, 2013
  • Identified as a leader based on publications in the scientific literature, role in the field and the recommendations of colleagues in the field, by a global management consultancy (whose confidentiality is being maintained but can be communicated), on perceptions of the pharmaceutical industry's medical activities. As health systems seek reform, they were interested in my opinions on the value of non-promotional interactions with the industry, 2013, New Jersey, USA
  • Listed in 2013 by BioMedLib (www.BioMedLib.com) as 1 in top 20 Articles published on the same topic. Sundell IB, Cortado RV, Koka PS: “Sulfatide--a new candidate for ART treatment in HIV-1 infection.” J Stem Cells; 2012; 7(1):61-72. PMID: 23550344.
  • Editorial Board Member, International Journal of Aids & Its Research (IJAR), Nuclei Online Publishers (NOP), Quincy, Massachusetts, USA, (http://www.nucleionline.org/international-journal-of-aids-its-research/, 2013 – Present
  • Editorial Board Member for the journal Molecular Biology and Genetic Engineering, Herbert Publications, United Kingdom, 2013 – Present
  • Editorial Board Member for the journal Archives of Cytology, Herbert Publications, United Kingdom, 2013 – Present
  • According to Carina Paraiso, Frontiers Editorial Project Manager (www.frontiersin.org/ | (www.twitter.com/FrontiersIn) Lausanne, Switzerland, our article "Placental membrane as a source of mesenchymal stem cells", by Sundell IB and Koka PS, in Journal of Stem Cells, highlights content that would be ideal to serve as a foundation for a (Frontiers Research Topic These community-driven article collections provide a forum to promote scientific discussion, and can be updated yearly to incorporate the latest research. Frontiers has partnered with Nature Publishing Group which shares their vision of a researcher-driven open-science platform. Communicated to Dr. Sundell on May 19, 2014.
  • Invited Continuing Medical Education (CME) lecture at Bangalore Medical College, Bangalore, June 2014
  • Editorial Board Member, Journal, Stem Cell Biology Research, Herbert Publications, UK, 2014
  • Frontiers, an open-access publishing partner of Nature Publishing Group sought proposals for Frontiers Research Topics, in particular for their section on Stem Cell Treatments in the journal Frontiers in Cell and Developmental Biology, 23 Sep 2014
  • Editorial Board Member, Indian Journal of Case Reports, Atharva Scientific Publications, Bhopal, India, 2014 – Present
  • Our article (Sundell IB, Cortado RV, Koka PS.) “Sulfatide a new candidate for ART treatment in HIV-1 infection.” J Stem Cells 2012; 7(1): 61-72] was ranked 8th in the top 20 articles of www.WIPIMD.com: Communicated on Oct. 16, 2014: http://sign-up.wipimd.com/urlu8c?srk=efe260f8296d1adaff076ecbce23d1126e58430a836cf77e6c6f95feab817709
  • Editor-in-Chief, Stem Cell Biology and Research, Herbert Publications, Regd. Off: Bedfordshire, United Kingdom; Editorial Off: Hyderabad, India, 2014 – Present. Journal website: www.hoajonline.com/stemcells
  • Editorial Member, Asian Pacific Journal of Microbiology Research, Academic Research Publishers, UK, 2014
  • Editorial Board Member, International Journal of Virology and AIDS, Lewes, Delaware, USA, 2014. editorialoffice.ijva@clinmedlibrary.com
  • Organizing Committee - Advisory Committee, International Conference on Translational Medicine in 21st Century “Stem Cell Transplantation: Current Status.” April 11-14, 2015, Bhopal, India
  • Honorable Editor, Journal of Human Virology and Retrovirology, https://medcraveonline.com/ * JHVRV * MedCrave Group, Danforth Road, Edmond, Oklahoma, USA, 2015 – Present, http://medcraveonline.com/JHVRV/editorial-board
  • Our paper “Ligament and Tendon Repair through Regeneration Using Mesenchymal stem cells” (published in Current Stem Cell Research & Therapy.2015 10(1):84-88) has been selected to be featured in the issue of World Biomedical Frontiers, because of its innovation and potential for significant impact. World Biomedical Frontiers [ISSN: 2328-0166] focuses on cutting-edge biomedical research from around the globe. Their website receives more than 8,000 visits per month from an international audience of academic and industrial researchers and developers, providing greater opportunity for our results to be recognized and appreciated, Year 2015
  • Frontiers Research Topics noticed that our Review “Adult Mesenchymal Stem Cells and Their Potency in the Cell-Based Therapy,” published in Journal of Stem Cells 2013; 8(1): 1-16 has already received 8 citations as communicated by Catriona Christodoulou on 10 August 2015 www.frontiersin.org | twitter.com/FrontiersIn Lausanne, Switzerland. Frontiers has pioneered the use of article-level metrics, which allows them to keep an eye on the “rising star” articles — even those of other publishers, which underscores the wide-ranging and growing interest for this work.
  • Editor, Journal of Virology and Current Research, Juniper Publishers, Ontario, California, USA, August 2015 – Present, http://juniperpublishers.com/index.php; virology@juniperpublishers.org; virology@juniperpublishers.us
  • Honorary Life Member, Society of Regenerative Medicine, SRMORG.IN, 2015
  • Editorial Board Member, ARC Journal of Surgery (AJS), ARC Publications, Pvt. Ltd., Hyderabad, India, Since November, 2015.
  • Editorial Board Member, Current Research in Stem Cell and Regenerative Medicine, Kenkyu Group, Hyderabad, India, since November, 2015, www.kenkyugroup.org/journal/26/Current-Research-in-Stem-Cell-and-Regenerative-Medicine
  • Adjudicator of PhD dissertation in Biotechnology, Sri Venkateswara Institute of Medical Sciences (SVIMS, TTD) University, Tirupati, India, 2016
  • Invited speaker at Akanksha Hospital & Research Institute (AHRI), Anand, Gujarat, India, July, 2016
  • Invited speaker at P D Patel Institute of Applied Sciences, Charotar University of Science & Technology (CHARUSAT), Changa-Anand, Gujarat, India, July 2016
  • Honorable Editor, Hematology & Transfusion International Journal, https://medcraveonline.com/ * HTIJ * MedCrave Group, Danforth Road, Edmond, Oklahoma, USA, October 2016 – Present, http://medcraveonline.com/HTIJ/editorial-board
  • Invitation to deliver a talk at the “International Conference on Atomic and Nuclear Physics,” November 17-18, 2016, Atlanta, USA
  • Invitation to be the speaker under Video Presentation category at 8th World Congress on Virology,” November 28-30, 2016, San Antonio, USA. Theme: “Exploring Novel Approaches in Virology”
  • Invitation to be Organizing Committee Member at “4th Global Applied Microbiology Summit,” Sept. 18-20, 2017, Dallas, USA. Theme: “One Platform to Gather World Renowned Microbiologists.” Microbiology 2017, PULSUS Medical Meetings. PULSUS - Established in 1984 and headquartered in London, UK, cmesociety.com
  • Invitation to be a Speaker/Delegate for the conference “Global Summit and Expo on Proteomics,” Valencia, Spain, November 09-11, 2017. Theme: “Translating Proteomics Technologies from Modern Life Science."
  • Invitation as a Speaker in the international quest “3rd World Congress & Expo on Oncology and Radiology” (Oncology & Radiology-2017), December 04-06, 2017, San Francisco, USA. Theme: “Latest Invention and Discoveries in Oncology & Radiology.”
  • Eminent Speaker invitation by PULSUS Group, “4th World Applied Microbiology Summit,” September 18-20, 2017, San Antonio, Texas, USA.
  • On the behalf of International Association of Advanced Materials (IAAM, www.iaamonline.org), invitation to submit abstracts for the 8th anniversary of Advanced Materials World Congress (AMWC, www.vbripress.com/amwc17), Singapore. The congress will be host on the Strait of Malacca - Conference Center, Mariner of the Seas, Royal Caribbean Cruise Ship, sailing from Singapore - Penang (Malaysia) – Singapore, February 04 – 08, 2018.
  • Invited as an Organizing Committee Member for the International Hematologists Summit (HIS - 2018), May 21-22, 2018 held at Valencia, Spain, http://www.scientificfederation.com/hematologists-summit-2018/
  • Invitations from The Athens Institute for Education and Research (ATINER), a world association of academics and researchers based in Athens, organized the following two panels-streams on "Stem Cells” as part of the 6th Annual International Conference on Health & Medical Sciences, May 7-8, 2018, Athens, Greece, and a stream on “Stem Cells Biology” as part of the 4th Annual International Conference on Biology, June 25-26, 2018, Athens, Greece.
  • Reviewer for Elsevier – Computers in Biology and Medicine, since 2018.
  • Invited to be Organizing Committee Member (OCM) for the first International Conference on Oncology and Hematology, June 2019, Dubai.

________________________________________________________________________________________________________________________________________________________

PATENT

In Vitro Tissue Culture Assay to Screen Potential Drugs for HCV, University of California (UC) Case No. 2001-067-1 (Hepatitis C Virus), approved in February 2007 in USA.
________________________________________________________________________________________________________________________________________________________

PUBLICATIONS (Chronological Order)

  1. Song PS, Koka P, Prezelin BB, Haxo FT. Molecular topology of the photosynthetic light-harvesting pigment complex, peridinin-chlorophyll a-protein from marine dinoflagellates. Biochemistry, 1976; 15: 4422-4427.
  2. Koka P, Song PS. The chromophore topography and binding environment of peridinin-chlorophyll a-protein from marine dinoflagellate algae. Biochim Biophys Acta, 1977; 495: 220-231.
  3. Koka P, Song PS. Protection of chlorophyll a by carotenoid from photodynamic decomposition. Photochem Photobiol, 1978; 28:509-515.
  4. Lee J, Koka P. Purification of blue fluorescence protein from the bioluminescent bacterium Photobacterium phosphoreum. Methods in Enzymology, 1978; 57: 226-234.
  5. Koka P, Lee J. Separation and structure of the prosthetic group of the blue fluorescence protein from the bioluminescent bacterium Photobacterium phosphoreum. Proc Natl Acad Sci USA, 1979; 76: 3068-3072.
  6. Small ED, Koka P, Lee J. Lumazine protein from the bioluminescent bacterium Photobacterium phosphoreum purification and characterization. J Biol Chem, 1980; 255: 8804-8810.
  7. Lee J. Carreira LA, Gast R, Irwin RM, Koka P, Small ED, Visser AJWG. Properties of a lumazine protein from the bioluminescent bacterium Photobacterium phosphoreum. Bioluminescence and Chemiluminescence, 1981; 103-112, Academic Press, New York.
  8. Koka P. Stimulation of Escherichia coli DNA photoreactivating enzyme activity by adenosine 5’-triphosphate. Biochemistry 1984; 23: 2914-2922.
  9. Koka P, Yunis J, Passarelli AL, Dubey DP, Faller DV, Yunis EJ. Increased expression of CD4 molecules on Jurkat cells mediated by human immunodeficiency virus Tat protein. J Virol 1988; 62:4353-4357.
  10. Koka P, Cecka JM. Sensitization and crossmatching in renal transplantation. Clinical Transplants 1989; 379-390.
  11. Koka P, Cecka JM. Sex and age effects in renal transplantation. Clinical Transplants 1990; 437-446.
  12. Koka P, van de Mark K, Faller DV. Trans-activation of genes encoding activation-associated human T-lymphocyte surface proteins by murine retroviral sequences. J Immunol 1991; 146:2417-2425.
  13. Lim EC; Chia D, Gjertson DJ, Koka P, Terasaki PI. In vitro studies to explain high renal allograft survival in IgA nephropathy patients. Transplantation 1993; 55:996-999.
  14. Koka P. Anti-HLA antibodies: Detection and effect on renal transplant function. Transplant Proc 1993; 25: 243-244.
  15. Koka P, Chia D, Terasaki PI, Chan H, Chia J, Ozawa M, Lim E. The role of IgA anti-HLA Class I antibodies in kidney transplant survival. Transplantation 1993; 56: 207-211.
  16. Koka P, He K, Camerini DC, Tran T, Yashar SS, Merrill JE. The mapping of HIV-1 gp160 epitopes required for interleukin-1 and tumor necrosis factor a production in glial cells, J Neuroimmunol 1995; 57:179-191.
  17. Koka P, He K, Zack JA, Kitchen S, Peacock W, Fried I, Tran T, Yashar SS, Merrill JE. Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor α, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J Exp Med 1995; 182: 941-952.
  18. Koka P, Merrill JE. The putative role of HIV-1 envelope proteins in the neuroimmunology and neuropathology of CNS AIDS. Immunology of HIV Infection, Ed: Gupta S, Plenum Press, New York, 1996; 417-435.
  19. Withers-Ward ES, Amado R, Koka PS, Jamieson BD, Kaplan AH, Chen ISY, Zack JA. Transient renewal of thymopoiesis in HIV infected human thymic implants following antiviral therapy. Nature Med 1997; 3: 1102-1109.
  20. Koka PS, Fraser JK, Bryson Y, Bristol GC, Aldrovandi GM, Daar ES, Zack JA. Human immunodeficiency virus type 1 inhibits multilineage hematopoiesis in vivo. J Virol 1998; 72: 5121-5127.
  21. Amado RG, Koka P, Zack JA. Modeling precursor cell gene therapy and HIV pathogenesis in the SCID-hu mouse. Cancer Res Ther Cont 1998; 7: 43-47.
  22. Koka PS, Jamieson BD, Brooks DG, Zack JA. Human immunodeficiency virus type-1 induced hematopoietic inhibition is independent of productive infection of progenitor cells in vivo. J Virol 1999; 73: 9089-9097.
  23. Uittenbogaart CH, Boscardin WJ, Anisman-Posner DJ, Koka PS, Bristol G, Zack JA. Interleukin-2 and Interferon- delay depletion of immature thymocytes after infection with HIV-1 in vivo. AIDS 2000; 14: 1317-1325.
  24. Koka PS, Brooks DG, Razai A, Kitchen CM, Zack JA. HIV-1 infection alters cytokine mRNA expression in the thymus. AIDS Res Hum Retr 2003; 19: 1-12.
  25. Koka PS, Reddy ST. Cytopenias in HIV infection: Mechanisms and alleviation of hematopoietic inhibition. Curr HIV Res 2004; 2: 275-282.
  26. Koka PS, Kitchen CM, Reddy ST. Targeting c-Mpl for revival of human immunodeficiency virus type 1-induced hematopoietic inhibition when CD34+ progenitor cells are re-engrafted into a fresh stromal microenvironment in vivo. J Virol 2004; 78: 11385-11392.
  27. Brooks DG, Cohen M, Jamieson BD, Poon B, Kitchen SG, Chow SA, Chen ISY, Zack JA, Koka PS. Rapid size dependent deletion of foreign gene sequences inserted into HIV-1 upon infection in vivo: Implications for vaccine development. Curr HIV Res 2005; 3: 377-392.
  28. Sundell IB, Koka PS. Thrombocytopenia in HIV infection: Impairment of platelet formation and loss correlates with increased c-Mpl and ligand thrombopoietin expression. Curr HIV Res 2006; 4: 106-117.
  29. Koka PS. Foreword: Stem Cells. J Stem Cells 2006; 1: p iii.
  30. Yunis EJ, Zuniga J, Koka PS, Husain Z, Romero V, Stern JNH, Fridkis-Hareli M. Stem cells in aging: Influence of ontogenic, genetic and environmental factors. J Stem Cells 2006; 1(2): 125-147.
  31. Sundell IB, Koka PS. Chimeric SCID-hu Model as a Human Hematopoietic Stem Cell Host that Recapitulates the Effects of HIV-1 on Bone Marrow Progenitors in Infected Patients. J Stem Cells 2006; 1(4): 283-300.
  32. Yunis EJ, Romero V, Diaz-Giffero F, Zuniga J, Koka P. Natural killer cell receptor NKG2A/HLA-E interaction dependent differential thymopoiesis of hematopoietic progenitor cells influences the outcome of HIV infection. J Stem Cells 2007; 2(4): 237-248.
  33. Koka PS, Khanna A. Foreword: A compendium on latest developments in stem cell research and cell therapy applications. J Stem Cells 2009; 4(2): 81-82.
  34. Zhang M, Poh TY, Louache F, Sundell IB, Yuan J, Evans S, Koka PS. Rescue of multi-lineage hematopoiesis during HIV-1 Infection by human c-mpl gene transfer and reconstitution of CD34+ progenitor cells in vivo. J Stem Cells 2009; 4(3): 161-177.
  35. Zhang M, Evans S, Yuan J, Ratner L, Koka PS. HIV-1 determinants of thrombocytopenia at the stage of CD34+ progenitor cell differentiation in vivo lie in the viral envelope gp120 V3 loop region. Virology 2010; 401(2):131-136. This Article, doi: 10.1016/j.virol.2010.03.005, has been "Featured on Antibody Resource"http://www.antibodyresource.com/search/antibodies/d52f4526-80a5-14f4-1241-11a6a9394170/CD38
  36. Zhang M, Dias P, Minev B, Koka PS. Induction, isolation and characterization human fetal hematopoietic cancer stem cells in vivo. J Stem Cells 2010; 5(1): 1-7.
  37. Sundell IB, Halder R, Zhang M, Maricic I, Koka PS, Kumar V. Sulfatide administration leads to inhibition of HIV-1 replication and enhanced hematopoiesis. J Stem Cells 2010; 5(1): 33-42.
  38. Yuan J, Devarajan A, Moya-Castro R, Zhang M, Evans S, Bourquard N, Dias P, Lacout C, Vainchenker W, Reddy ST, Koka PS. Putative innate immunity of antiatherogenic paraoxonase-2 via STAT5 signal transduction in HIV-1 infection of hematopoietic TF-1 cells and in SCID-hu mice. J Stem Cells 2010; 5(1): 43-48.
  39. Sundell IB, Koka PS. Placental membrane as a source of mesenchymal stem cells. J Stem Cells 2010; 5(2): 83-88. [Listed in 2012 by BioMedLib (www.BioMedLib.com) as rank 1 in top 20 Articles published on the same topic. Re-listed in 2013 by www.BioMedLib.com as our paper continues to rank 1 in top 20 Articles published on the same topic.]
  40. Bhargav H, Nagarathna R, Nagendra HR, Tekur P, Koka PS. Potential yoga modules for treatment of hematopoietic inhibition in HIV-1 infection. J Stem Cells 2010; 5(3): 129-148.
  41. Sundell IB, Cortado RV, Koka PS. Sulfatide ~ a new Candidate for ART treatment in HIV-1 infection. J Stem Cells 2012; 7(1): 61-72. [Listed in 2013 by BioMedLib (www.BioMedLib.com) as rank 1 in top 20 Articles published on the same topic. Ranked 8 in the top 20 articles of www.WIPIMD.com Oct 2014.]
  42. Bhargav H, Huilgol V, Metre K, Sundell IB, Tripathi S, Nagaratna R, Jadhav M, Raghuram N, Nagarathna R, Nagendra HR, Koka PS. Evidence for extended age dependent maternal immunity to virus in infected children: mother to child transmission of HIV infection and potential interventions including role of sulfatides of the human fetal adnexa and complementary or alternative medicines. J Stem Cells 2012; 7(3): 127-153.
  43. Bhargav H, Metri K, Nagarathna R, Nagendra HR, Koka PS. Enhancement of cancer stem cell susceptibility to conventional treatments through complementary yoga therapy: possible cellular and molecular mechanisms. J Stem Cells 2012; 7(4): 261-267.
  44. Ram A, Nagarathna R, Rao RM, Bhargav H, Koka PS, Tripathi S, Raghuram NV, Kodaganur GS, Nagendra HR. Development and validation of a need based integrated yoga program for cancer patients: A retrospective study. J Stem Cells 2012; 7(4): 269-282.
  45. Das M, Sundell IB, Koka PS. Potency of adult mesenchymal stem cells in the cell based therapy. J Stem Cells 2013; 8(1): 1-16. This article has been cited in Role of ECM/peptide coatings on SDF-1α triggered mesenchymal stromal cell migration from microcarriers for cell therapy. Levato, R., Planell, J.A., Mateos-Timoneda, M.A., Engel, E. Acta Biomaterialia, volume 18, issue , year 2015, pp. 59 – 67. Frontiers Research Topics noticed that this Review of ours has already received 8 citations as communicated by Catriona Christodoulou www.frontiersin.org | twitter.com/FrontiersIn Lausanne, Switzerland, on 10 August 2015. Frontiers have pioneered the use of article-level metrics, which allows them to keep an eye on the “rising star” articles — even those of other publishers, which underscores the wide-ranging and growing interest for this work.
  46. Metri K, Bhargav H, Chowdhury P, Koka PS. Ayurveda for chemo-radio therapy related side effects in cancer patients. J Stem Cells 2013; 8(2): 115-130.
  47. Duggal R, Minev B, Geissinger U, Wang H, Chen NG, Koka PS, Szalay AA. Biotherapeutic approaches to target cancer stem cells. J Stem Cells 2013; 8(3/4): 135-150.
  48. Ramdass B, Chowdhary A, Koka PS. Hematological malignancies: disease pathophysiology of leukemic stem cells. J Stem Cells 2013; 8(3/4): 151-188.
  49. Ramdass B, Duggal R, Minev B, Chowdhary A, Koka PS. Functional role of solid tumor stem cells in disease etiology and susceptibility to therapeutic interventions. J Stem Cells 2013; 8(3/4): 189-232.
  50. Ramdass B, Chowdhary A, Koka PS. Cancer initiating cells as target for prevention of recurring disease etiology: role of these malignant putative progenitor cells in relapse or metastasis of human cervical carcinoma. J Stem Cells 2013; 8(3/4): 233-251.
  51. Koka PS. Biomarker Discovery and Biotherapeutics Applications of Photosynthetic Light-Harvesting and Bioluminescence Light-Emitting Chromophore-Protein Complexes in Stem Cell Biology and Regenerative Medicine. J Stem Cells 2014; 9(3): 127-133.
  52. Ramdass B, Koka PS. Ligament and tendon repair through regeneration using mesenchymal stem cells. Curr Stem Cell Res Ther 2014; 10(1):84-88, 2014 Oct 2 [Epub ahead of print]. [This paper has been selected to be featured in the issue of World Biomedical Frontiers because of its innovation and potential for significant impact. World Biomedical Frontiers [ISSN: 2328-0166] focuses on cutting-edge biomedical research from around the globe. This website receives more than 8,000 visits per month from an international audience of academic and industrial researchers and developers, providing greater opportunity for our results to be recognized and appreciated. Year 2015.
  53. Govindappa M, Sadananda TS, Channabasava, Ramachandra YL, Chandrappa CP, Padmalatha RS, Koka PS. In vitro and in vivo antidiabetic activity of lectin (N-acetyl-galactosamine, 64 kDa) isolated from endophytic fungi, Alternaria species from Viscum album on alloxan induced diabetic rats. Integr Diabetes Obesity 2015; 1(1): 11-19, doi: 10.15761/IOD.1000104
  54. Kulkarni A, Govindappa MC, Ramachandra YL, Koka P. GC-MS analysis of methanol extract of Cassia fistula and in vitro anticancer activity on prostate cancer cell line. Indo Amer J Pharm Res 2015; 5(2): 937-944.
  55. Kulkarni A, Govindappa M, Channabasava, Chandrappa CP, Ramachandra YL, Koka PS. Phytochemical analysis of Cassia fistula and its in vitro antimicrobial, antioxidant and anti-inflammatory activities. Adv Med Plant Res 2015; 3(1): 8-17.
  56. Bansal H, Bansal A, Kachhap MN, Chowdhary A, Koka PS. Therapeutic application of bone marrow derived stem cells in a patient with methanol induced blindness. J Stem Cells 2015; 10(1): 1-11.
  57. Koka PS. Potential Safer Drug for Containment of Lentivirus Infection and Ensuing Cytopenias: Necessity of Clinical Trials in Control and Infected Patients. J Hum Virol Retr Virol 2015; 2(4): 00050. DOI: 10.15406/jhvrv.2015.02.00050
  58. Rao KS, Chakrabarti SK, Dongare VS, Chetana K, Ramirez CM, Koka PS, Deb KD. Antiaging Effects of an Intensive Mind and Body Therapeutic Program through Enhancement of Telomerase activity and Adult Stem Cell Counts. J Stem Cells 2015; 10(2): 107-125.
  59. Bansal H, Chaparia Y, Agrawal A, Koka PS. Reversal of methanol induced blindness in adults by autologous bone marrow mononuclear stem cells: a case-series. J Stem Cells 2015; 10(2): 127-139.
  60. Ramdass B, Koka PS. Supplementary: Ligament and Tendon Repair through Regeneration Using Mesenchymal Stem Cells. Current Stem Cell Research & Therapy 2015 10(1):84-88) World Biomedical Frontiers [ISSN: 2328-0166] 2015
  61. Koka PS, Pavithra V. The Role of Poietins in the Alleviation of Cytopenias in HIV Infection. J Hum Virol Retr Virol 2015; 2(5): 00055. DOI: 10.15406/jhvrv.2015.02.00055
  62. Srikruthi N, Deb KD, Koka PS. An Introduction to Stem Cells. www.thinkscience.in
  63. Koka PS. Degeneration vs Regeneration.J Stem Cells 2015; 10(3): 157-158.
  64. Padmanabhan U, Chowdhary AS, Dahake R, Koka PS. Vaccines against HIV. J Virol Curr Res 1(1): JVCR.MS.ID.555554 (2015)
  65. Koka PS. Efficacy of modern drugs against recurrence of hepatitis C virus (HCV) in co-infected HIV infected patients. J Virol Curr Res 1(2): JVCR.MS.ID.555557 (2015)
  66. Bhargav H, Srinivasan TM, Varambally S, Gangadhar BN, Koka PS. Effect of Mobile Phone Induced Electro-magnetic Field on Brain Hemodynamics and Human Stem Cell Functioning: Possible Mechanistic Link to Cancer Risk and Early Diagnostic Value of Electro-photonic Imaging. J Stem Cells 2015; 10(4): 287-294.
  67. Koka PS. HIV and HCV: Intractability of Vaccine Development. CuttingEdge 2016; 5(11): 9-12, https://www.spincotech.com/
  68. Verma P, Bansal H, Agrawal A, Leon J, Sundell IB, Koka PS. Evaluation of bone marrow processing protocol for therapeutic applications via culture and characterization of mesenchymal stem cells. J Stem Cells 2016; 11(1): 3-13.
  69. Bansal H, Singh L, Agrawal A, Leon J, Sundell IB, Koka PS. Therapy with bone marrow derived autologous adult stem cells in quadriparesis due to motor neuron disease. J Stem Cells 2016; 11(1): 15-23.
  70. Bansal H, Verma P, Agrawal A, Leon J, Sundell IB, Koka PS. A short study report on bone marrow aspirate concentrate cell therapy in ten South Asian Indian patients with autism. J Stem Cells 2016; 11(1): 25-36.
  71. Bansal H, Singh L, Verma P, Agrawal A, Leon J, Sundell IB, Koka PS. Administration of Autologous Bone Marrow derived Stem Cells for Treatment of Cerebral Palsy Patients: A Proof of Concept. J Stem Cells 2016; 11(1): 37-49.
  72. Bansal H, Verma P, Agrawal A, Leon J, Sundell IB, Koka PS. Autologous bone marrow derived stem cells in spinal cord injury. J Stem Cells 2016; 11(1): 51-61.
  73. Nandeesh N, Janardhan K, Subramanian V, Ashtekar AB, Srikruthi N, Koka PS, Deb KD. Treatment of AVN using Autologous BM Stem Cells and Activated Platelet derived Growth Factor Concentrates. J Stem Cells 2016; 11(3): 135-148.
  74. Jyothi NS, Koka PS. Need for in vivo triggering of homeostasis to repair irreversible tissue degeneration by stem cells through innate and invasive regenerative processes. J Stem Cells 2016; 11(3): 171-179.
  75. Koka PS. Mesenchymal stem cells in androgenic alopecia: hair loss regeneration. J Stem Cells 2016; 11(4): 181-182.
  76. James R, Chetry R, Subramanian V, Ashtekar A, Srikruthi N, Ramachandran S, Koka PS, Deb KD. Platelet-rich Plasma Growth Factor concentrated spray (Keratogrow ®) as a Potential Treatment for Androgenic Alopecia. J Stem Cells 2016; 11(4): 183-189.
  77. James R, Chetry R, Subramanian V, Ashtekar A, Srikruthi N, Ramachandran S, Koka PS, Deb KD. Platelet-rich Plasma as a Potential Treatment for Androgenic Alopecia. J Stem Cells 2016; 11(4): 191-199.
  78. Mahapatra S, Subramanian V, James R, Deb KD, Koka PS. Follicular Transection Rates in Follicular Unit Extraction Method. J Stem Cells 2017; 12(1): 1-6.
  79. Koka PS, Sundell IB Padmanabhan U, Minev B, Setzer TJ, Chowdhary A. Potential Origins of Cancer Stem Cells in the Disease Evolution and its Etiology. J Stem Cells 2017; 12(1): 25-31.
  80. Koka PS. Vertical Transmission of Virus Infections – Placenta as Facilitator or Inhibitor. J Hum Virol Retr Virol 2017; 5(3); 00152.
  81. Koka PS, Chowdhary A. Assessment of necessity of transfusions in vector-borne primary and secondary infections. Hematol Transfus Intl J 2017; 4(5): 00097.
  82. Bansal H, Comella K, Leon J, Verma P, Agrawal D, Koka P, Ichim T. Intra-articular Injection in the Knee of Adipose Derived Stromal Cells (Stromal Vascular Fraction) and Platelet Rich Plasma for Osteoarthritis. J Transl Med 2017; 15(1): 141 doi: 10.1186/s12967-017-1242-4.
  83. Koka PS. Lineage origins of cancer stem cells. CHARUSAT J 2017; 1(1): 17-20.
  84. Jyothi NS, Koka PS. A Concept of Inducing Innate Regeneration through Cell Free Regenerative Medicine - A Possible Therapeutic Approach for the Ischemic Cerebrovascular Insult. J Stem Cells 2017; 12(3): 113-132.
  85. Koka PS. Need for Improved Contrast Dyes to Prevent Life-Threating Consequences. Hematol Transfus Intl J 2018; 6(1): 00144. DOI: 10.15406/htij.2018.06.00144
  86. Koka PS. The often overlooked deleterious malignant effects of mesenchymal stem cells. Curr Res Stem Cell Regen Med. Manuscript in preparation.
  87. Koka PS, Palep HS, Bichile S, Chowdhary A, Lele RD. Thalassemia in Adult Patients: Allogeneic CD34+ Progenitor Cells for Increased Success Rate in Hematopoietic Stem Cell Transplantation. Manuscript in preparation.
  88. Padmanabhan U, Dahake R, Chowdhary A, Koka PS. HIV-1 inhibits multi-lineage hematopoiesis via microRNA host factors secreted by infected CD4+ T cells. Manuscript submitted.

________________________________________________________________________________________________________________________________________________________

EDITED BOOKS, Editor: Koka PS, Nova Science Publishers, New York, USA

Journal of Stem Cells is a peer-reviewed journal that publishes four issues per year. The journal is owned and operated by Nova Science Publishers and funded entirely by subscription revenue and author-optional publication services.

Instructions for Reviewers
Requests to serve as a Reviewer should be sent to the Editor-in-Chief, Dr. Prasad Koka, at prasad.koka@novapublishers.com.

Reviewers who repeatedly decline to review manuscripts following their formal inclusion on the journal's website will be removed from the list of reviewers at the Editor's discretion.

Serving reviewers are advised to recommend their colleagues in the event they are unable to review the assigned manuscript.

Contributing authors can also recommend referees in their fields of expertise for reviewing their articles if there is no conflict of interest.

Notes for Authors
There is no charge to submit your article and have it published in the journal, and there is no charge for color printing. Nova offers a number of optional publication services that carry fees, but authors are not required to select these services, and the services won’t be offered until after acceptance of the articles. These services include Open Access, article offprints, discounted print copies of the journal issue, and licenses for use of the published articles.

Submission of an article implies that the authors will assign the copyright to Nova if their article is accepted for publication. A standard Copyright Transfer Form will be provided to the Corresponding Author of each article during the page proof stage of production.

Authors will receive a complimentary PDF of the full final issue and a complimentary PDF of his or her final article upon publication.

Authors may deposit and display the proofed versions of their articles in and on their personal non-commercial and affiliate non-commercial repositories and websites at any time. The same may be done with their final published articles only after a period of one year has elapsed from the day of publication.

Peer-Review
Original or review articles submitted to Journal of Stem Cells are sent for peer review to at least three reviewers. This number of reviewers can increase if some of the reviewers fail to respond, or if there is a conflict between the reviewers on the decision making process by the Editor. If some of the reviewers' comments are severely adverse in nature then the Editor will seek the response of additional reviewer(s). A final decision to accept or reject the article is made by the Editor after seeking a suitable response from the authors to the reviewers' comments. The revised version of the article may be sent back to the same reviewers before a decision is made. The authors' responses and rebuttals on the reviewer(s) comments on the revised version of the manuscript will determine the decision of acceptance or rejection of the manuscript / article.

Manuscript Submissions
Before submitting your article, please read the complete notes and instructions below to ensure that you understand Nova’s manuscript requirements and publication procedures and that you are in compliance with the ethical standards rightfully set forth by Nova, the publishing industry, and the scientific community.

Articles should be submitted by email to the Editor-in-Chief listed below.

Prasad S Koka, PhD
E-mail: prasad.koka@novapublishers.com

All abstracts and articles must be written in English with references in standard Roman script.

It is understood that articles submitted to the journal have not been submitted elsewhere for simultaneous publication consideration and have not been previously published, in whole or in part, unless the new article is an expansion of the original, in which case full transparency of the re-used portions must be provided.

Manuscript Preparation
The Journal will be published in the standard letter size with soft cover. The articles will include peer-reviewed original research and review articles, brief reports, rapid communications, mini- or short reviews, news items, book reviews, and letters to the Editor. Regular research articles will consist of an abstract, introduction, materials and methods, results, discussion, acknowledgements, table and figure legends, and references.

The word count limitations for all submissions will be considered on case-by-case basis with importance to the delivery of the scientific information to the readers. Cover illustration of scientific significance for a specific issue of the Journal from a contributing author will be considered by the Editor in consultation with the Publisher. The authors will submit to the Editor an electronic version of the article including cover letter, text, tables, figures, and illustrations as accepted for publication. The Editor reserves the right to reject publication of an article that does not meet these requirements or in his opinion is not original. Personal and institutional subscriptions are available.

An average issue will constitute between 100-150 pages and will be 8.5 x 11 double column. Contributors trying to submit articles above 4MB in size should contact the Editor for instructions on how to submit the article through our FTP server. For final submission of publication, the manuscript text should be in MS Word and the figures, graphics, and illustrations should be in TIFF format.

In-text references should be either author-identified or reference-number-identified and placed in square brackets on the line, e.g., [37]. Examples of acceptable forms of reference lists at the end of the article are as follows:

Author, AB; Author, CD. Title of journal article. Title of journal, year of publication, volume number, first page-last page.

Publication Ethics
Nova is committed to maintaining trust in the journal, the value of authorship, and the integrity of science. Authors should be eager to help us maintain these standards. The following guidelines are provided to help authors avoid the appearance of ethical misconduct in their research and to help ensure adherence to the best practices set forth by national and international professional and regulatory bodies.

Plagiarism is a blight on the scientific community and a crime. The unauthorized use or close imitation of another’s language, text, data, ideas, or theories is prohibited. In all instances of authorized use, full credit to and representation of the original author’s work must be provided. It is the authors’ responsibility to secure permission for the use of copyrighted material. Nova uses software during the page proof stage of production to check for instances of plagiarism. Articles will not be accepted for publication by the Publisher until articles are proven not to consist of plagiarized material. The journal will investigate all reports and suspicions of plagiarism. Authors suspected of plagiaristic misconduct will be contacted and given the opportunity to prove the validity of their work and refute the allegations. All instances of proven plagiarism will be reported to the Publisher by the editorial office, and the author’s institute, and other governing bodies will be contacted as necessary. Plagiarized articles already accepted for publication will be cancelled, and plagiarized articles that have already been published will be retracted and denounced in a public erratum.

It is important that all authors and organizations where the research has been carried out have consented to the work’s submission and that all authors have significantly contributed.

In order to establish transparency in research, authors should be sure to provide the following items.

1) Information regarding the source(s) of the work’s funding;
2) All financial and non-financial potential conflicts of interest;
3) A statement of informed consent for all studies that involve human participants;
4) A statements of human rights for all studies that involve human participants;
5) A statement on the humane treatment and proper welfare of all animals involved in the study.

The appropriate statements are provided below. They should be included in the article’s text in a section titled Ethical Compliance. This section should immediately precede the References section.

1) Sources of Funding
Please provide the names of all funding agencies, research grants, and grant numbers.

Statement
Source of Funding: This study was funded by ____________________.

2) Potential Conflicts of Interest
Authors are required to disclose all personal and professional relationships and interests that can be viewed as potentially imparting bias in the work. Readers are entitled to this information and to their own conclusions and perceptions of conflict. Potential conflicts could be financial relationships, employment, sponsorships, public holdings, competing interests, spousal interests, personal relationships, personal beliefs, etc.

Statement
a) Disclosure of Interest: The authors declare that they have no conflict of interest.

or

b) Disclosure of Interest:

3) Informed Consent
Study participants have the right to decide how the identifiable personal information gathered on them is used. It is essential that all participants (or guardians) give their written informed consent to participate in the study and its subsequent publication.

Statement
Informed consent was obtained from each individual participant involved in this study.

4) Statement of Human Rights
The wellbeing of human subjects takes precedence over the interests of science. If a study involves human participants, authors should include a statement that the study was conducted in accordance with the 1964 Declaration of Helsinki and its subsequent amendments.

Statement
This study was conducted in accordance with the 1964 Declaration of Helsinki and its subsequent amendments.

5) Statement of Animal Welfare
All studies that involve animals should contain a statement that the study and its procedures have been approved by their affiliate institutional research ethics committee.

Statement
All animals involved in this study were treated in accordance with the ethical standards set forth by the institution at which the study was conducted.

Committee on Publication Ethics
Nova and its editors follow the Codes of Conduct and Best Practice Guidelines set forth by the Committee on Publication Ethics (COPE). These codes and guidelines are valuable instructions that ensure transparency and fairness in research and publishing. The single document provides steps for submissions, peer-review, confidentiality, the creation and maintenance of editorial boards, editorial responsibilities and decision-making, communication policy, appeal procedures, handling complaints and instances of misconduct, quality assurance, publishing corrections and retractions, adherence to national and international ethics guidelines, and many more aspects of the publication process.

The COPE Codes of Conduct and Best Practice Guidelines can be read at the link below. We recommend your familiarity with them while you publish with Nova and any other scientific publisher.
https://publicationethics.org/resources/code-conduct

If you notice any ethical misconduct in Nova’s publications, please contact us.

Publisher’s Office
Nova Science Publishers, Inc.
415 Oser Avenue, Suite N
Hauppauge, New York 11788, USA
Phone: (631) 231-7269
E-mail: nova.main@novapublishers.com

Advertising Opportunities
Please contact our office using the information above.

Please click here to browse and purchase individual volumes and issues.

You have not viewed any product yet.